跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
TAVLESSE 150 MG COMPRIMIDOS RECUBIERTOS CON PELICULA - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
TAVLESSE 150 MG COMPRIMIDOS RECUBIERTOS CON PELICULA
Approved
STANDARD
TAVLESSE 150 MG COMPRIMIDOS RECUBIERTOS CON PELICULA
Instituto Grifols S.A.
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Jun 3, 2020
Approval ID
9cd57f9ad08f82e4
Company
Instituto Grifols S.A.
Type
Standard
Approval Details
Approval Id
9cd57f9ad08f82e4
Drug Cima Aemps Name
TAVLESSE 150 MG COMPRIMIDOS RECUBIERTOS CON PELICULA
Register Number
1191405002
Holder Company Name
Instituto Grifols S.A.
Marketing Company Name
Instituto Grifols S.A.
Holder Company Detail Path
/organization/instituto-grifols-sa
Marketing Company Detail Path
/organization/instituto-grifols-sa
Authorization Date
2020-06-03
Dosage Form
COMPRIMIDO RECUBIERTO CON PELÍCULA
Dose
150 mg
Route Of Administration
VÍA ORAL
Prescription Type
Uso Hospitalario
Commercialized
Yes
Company Name
Instituto Grifols S.A.
Company Detail Path
/organization/instituto-grifols-sa
Company Information
Pharmaceutical Company Name
Instituto Grifols, S.A.
Name En
Instituto Grifols, S.A.
Country Name
Spain
City Name
parets del valles,barcelona,country_es
Address
CALLE CAN GUASCH (PG LEVANTE) 2
Active Ingredients
FOSTAMATINIB DISODIO HEXAHIDRATO
189.3 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Jun 3, 2020
Approval ID
9cd57f9ad08f82e4
Type
Standard
Back to CIMA-AEMPS Approvals
